Breaking News

Celltrion and Teva announced that the U.S. FDA has approved HERZUMA, a HER2/neu receptor antagonist biosimilar to HERCEPTIN for the following indications: Adjuvant Breast Cancer of HER2 overexpressing node positive or node negative breast cancer; as part of a treatment regimen consisting of doxorubicin, cyclophosphamide, and either paclitaxel or docetaxel; as part of a treatment regimen with docetaxel and carboplatin. Metastatic Breast Cancer; in combination with paclitaxel for first-line treatment of HER2-overexpressing metastatic breast cancer; as a single agent for treatment of HER2-overexpressing breast cancer in patients who have received one or more chemotherapy regimens for metastatic disease. In these indications, patients should be selected for therapy based on an FDA-approved companion diagnostic for a trastuzumab product.

Pretium Resources is pleased to report that it has received the amended permits to increase the Brucejack Mine production rate to 3,800 tonnes per day from the BC Ministry of Energy, Mines and Petroleum Resources and the BC Ministry of Environment and Climate Change Strategy. The amended permits allow for a production increase to an annual rate of 1.387 million tonnes from 0.99 million tonnes (daily average of 3,800 tonnes from 2,700 tonnes). Minor mill upgrades to support the production rate increase are required and will be completed during regularly scheduled mill shutdowns. A specific timeline for ramp-up to the 3,800 tonnes per day production rate along with an updated mine plan is expected in the first quarter of next year.

Sonoma Pharmaceuticals (SNOA) announced a series of management changes. The board of directors named Frederick Sandford as Sonoma's CEO and interim CFO. He assumed the role on December 11 and, upon joining the company, also joined the board. Sandford has over 30 years of experience leading companies in several industries and at various stages. Most recently, Sandford transformed Command Center (CCNI) into a profitable enterprise, with nearly $100M in revenue. During his tenure at Command Center, he led the company to uplist on Nasdaq. Sonoma also announced that Jim Schutz and Bob Miller resigned from their positions as CEO and CFO respectively. Jim Schutz also resigned from the board.

On December 13, 2018, Ecology and Environment Inc. received, as expected, a formal notification from the Listing Qualifications Department of the Nasdaq Stock Market stating that the company is not in compliance with the requirements for continued listing under Nasdaq Listing Rule 5250c1 because it did not file its Quarterly Report on Form 10-Q for the period ended October 27, 2018, and because the Company remains delinquent in filing its Annual Report on Form 10-K for the fiscal year ended July 31, 2018. As described in the company's Current Report on Form 8-K dated December 12, 2018 and Form 12b-25 dated December 12, 2018, as filed with the Securities and Exchange Commission, the filing of the 2019 First Quarter Report is delayed pending the completion and filing of the 2018 Annual Report, including the completion of the restatement of the company's consolidated financial statements for the fiscal years ended July 31, 2017 and 2016.

Luther Burbank announced it has adopted a systematic repurchase plan to facilitate the repurchase of shares as part of its previously authorized stock repurchase program. The plan enables shares to be purchased during an otherwise self-imposed blackout period between the fifteenth day of the last month of the quarter and the reporting of the company's financial results. The company had approximately $15M available under its outstanding repurchase authorization as of September 30. The plan is effective from December 17, until two days following the company's release of its year-end financial results. Repurchases are subject to SEC regulations as well as certain price, market, volume and timing constraints as defined in the plan. There can be no assurance as to the exact number, or aggregate value, of shares of common stock that may be repurchased by the company.